These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1999519)

  • 21. Refractory anti-laminin γ1 pemphigoid with psoriasis vulgaris successfully treated by double-filtration plasmapheresis.
    Ohata C; Fukuda S; Ishii N; Koga H; Hamada T; Furumura M; Hashimoto T
    Eur J Dermatol; 2013; 23(5):715-6. PubMed ID: 24126071
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of bullous pemphigoid during secukinumab treatment for psoriasis.
    Ho PH; Tsai TF
    J Dermatol; 2017 Sep; 44(9):e220-e221. PubMed ID: 28543960
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cyclosporin in the treatment of bullous pemphigoid: preliminary study].
    Barthélémy H; Thivolet J; Cambazard F; Bendelac A; Mauduit G; Granier F; Frappaz A
    Ann Dermatol Venereol; 1986; 113(4):309-13. PubMed ID: 3532906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bullous pemphigoid during ustekinumab therapy in a psoriatic patient.
    Onsun N; Sallahoglu K; Dizman D; Su Ö; Tosuner Z
    Eur J Dermatol; 2017 Feb; 27(1):81-82. PubMed ID: 27777186
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report.
    Yun JS; Scardamaglia L; Tan CG; McCormack CJ
    Australas J Dermatol; 2022 May; 63(2):e155-e158. PubMed ID: 35138643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psoriasis and pemphigoid].
    Barba A; Leoni A; Peroni A
    G Ital Dermatol Venereol; 1985; 120(1):75-7. PubMed ID: 3891598
    [No Abstract]   [Full Text] [Related]  

  • 27. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
    Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
    [No Abstract]   [Full Text] [Related]  

  • 28. Delayed onset of bullous pemphigoid after PUVA and sunlight treatment of psoriasis.
    Albergo RP; Gilgor RS
    Cutis; 1982 Nov; 30(5):621-4. PubMed ID: 6756797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of anti-laminin γ1 (p200) pemphigoid with psoriasis vulgaris successfully treated with apremilast.
    Waki Y; Kamiya K; Komine M; Maekawa T; Murata S; Ishii N; Hashimoto T; Ohtsuki M
    Eur J Dermatol; 2018 Jun; 28(3):413-414. PubMed ID: 29619999
    [No Abstract]   [Full Text] [Related]  

  • 30. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
    Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
    J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.
    Wang TS; Tsai TF
    Acta Derm Venereol; 2014 Jan; 94(1):108-9. PubMed ID: 23624752
    [No Abstract]   [Full Text] [Related]  

  • 32. [Psoriasis and pemphigoid (author's transl)].
    Olmos L; de Diego V
    Dermatologica; 1981; 163(1):105-12. PubMed ID: 7024004
    [No Abstract]   [Full Text] [Related]  

  • 33. Coexistence of psoriasis vulgaris and bullous diseases.
    Grunwald MH; David M; Feuerman EJ
    J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):224-8. PubMed ID: 3900156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab.
    Fukada N; Suzuki T; Aoyama K; Kinjo A; Yamazaki K; Sato T
    J Dermatol; 2023 Feb; 50(2):e72-e73. PubMed ID: 35904019
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-laminin-gamma 1 Pemphigoid with Generalized Pustular Psoriasis and Psoriasis Vulgaris.
    Fujimura Y; Natsuga K; Hamade Y; Nomura Y; Kaku Y; Muramatsu R; Shimizu H
    Acta Derm Venereol; 2016 Jan; 96(1):120-1. PubMed ID: 26074471
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidental amelioration of bullous pemphigoid during ixekizumab treatment for psoriasis.
    Lu L; Yu Y; Zhang J; Fan X; Qi Y; Lin B
    J Dermatol; 2022 Jan; 49(1):e13-e15. PubMed ID: 34633684
    [No Abstract]   [Full Text] [Related]  

  • 37. Efalizumab-induced bullous pemphigoid.
    Duong TA; Buffard V; André C; Ortonne N; Revuz J; Bagot M; Roujeau JC
    J Am Acad Dermatol; 2010 Jan; 62(1):161-162. PubMed ID: 20082902
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment with guselkumab of anti-p200 pemphigoid associated with plaque psoriasis.
    Kitayama S; Makino T; Kataoka K; Mori S; Takemoto K; Furukawa F; Torai R; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
    J Dtsch Dermatol Ges; 2024 May; 22(5):713-715. PubMed ID: 38593343
    [No Abstract]   [Full Text] [Related]  

  • 39. Ixekizumab successfully treated refractory psoriasis concurrent bullous pemphigoid.
    Xiao Y; Gu Y; Xia D; Zhou X; Li W
    J Dermatol; 2023 Feb; 50(2):e76-e78. PubMed ID: 36028948
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bullous pemphigoid induced by photochemotherapy of psoriasis. Apropos of 2 cases, with a review of the literature].
    Brun P; Baran R
    Ann Dermatol Venereol; 1982; 109(5):461-8. PubMed ID: 6753695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.